PointofLaw.com
 Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  
   
 
   

 

 

"Overwarning, Undercuring"



In City Journal, Marie Gryphon explores the need for preemption if the FDA is to stop the problem of overwarning. (I am quoted.) Earlier: Feb. 25; Jan. 2; Mar. 2006.

 

 


Rafael Mangual
Project Manager,
Legal Policy
rmangual@manhattan-institute.org

Katherine Lazarski
Manhattan Institute
klazarski@manhattan-institute.org

 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.